The Noguchi Memorial Institute for Medical Research (NMIMR) has commissioned the FACS Discover S8 Cell Sorter, the most advanced of its kind ...

Jeffrey William Henderson, a director at Becton Dickinson & Co (NYSE:BDX), recently acquired 1,500 shares of the company's common stock. The purchase, which took place on February 10, 2025, was made ...

Bard Peripheral Vascular, a subsidiary of Becton, Dickinson and Co., has reported 30 serious injuries and four deaths linked to the device due to a potential risk of helix fractures or breakages ...

Last week, readers were most interested in a story about BD's plan to separate its Biosciences and Diagnostics Solutions business by the end of 2026.

Citi analyst Joanne Wuensch maintained a Buy rating on Becton Dickinson (BDX – Research Report) today. The company’s shares closed last Friday ...

Major stock indexes closed higher on Friday, driven by corporate earnings reports from tech firms like Alphabet and Amazon.

Activist Starboard took a position in Becton Dickinson, calling for the company to sell its life sciences business. The ...

William Blair analyst A. Brackmann anticipates that the medical instruments supplier will post earnings of $3.34 per share for […] ...

Life science real estate developer Breakthrough Properties bought the three-building Muse complex at 3030, 3040 and 3050 ...

Becton Dickinson & Co. closed 9.83% short of its 52-week high of $251.99, which the company reached on February 3rd.